NEXGEL, Inc. (NXGLW) stock
NXGLWNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as NXGL
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026Score 6/3072% below fair value
$0.01+0.00 (0.00%)
Close on Oct 30, 2026Market cap $34.21MP/E –Yield –
Nexgel gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Nexgel's gross profit for the twelve months ending Jun 30, 2026 was $4.23M, down 9.5% year over year. For fiscal 2025 it was $4.51M, up 64.1% from the year before. The highest annual figure on record is $4.51M in fiscal 2025.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.51M | +64.1% |
| FY2024 | Dec 31, 2024 | $2.75M | +634.8% |
| FY2023 | Dec 31, 2023 | $374.00K | +46.1% |
| FY2022 | Dec 31, 2022 | $256.00K | +3100.0% |
| FY2021 | Dec 31, 2021 | $8.00K | – |
| FY2020 | Dec 31, 2020 | -$291.00K | – |
| FY2019 | Dec 31, 2019 | -$137.00K | -126.7% |
| FY2018 | Dec 31, 2018 | $514.00K | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.11M | -11.8% |
| Q1 FY2026 | Mar 31, 2026 | $1.06M | -10.7% |
| Q4 FY2025 | Dec 31, 2025 | $819.00K | -23.7% |
| Q3 FY2025 | Sep 30, 2025 | $1.24M | +7.6% |
| Q2 FY2025 | Jun 30, 2025 | $1.26M | +329.4% |
| Q1 FY2025 | Mar 31, 2025 | $1.19M | +642.5% |
| Q4 FY2024 | Dec 31, 2024 | $1.07M | – |
| Q3 FY2024 | Sep 30, 2024 | $1.16M | +235.8% |
| Q2 FY2024 | Jun 30, 2024 | $293.00K | +67.4% |
| Q1 FY2024 | Mar 31, 2024 | $160.00K | – |
| Q4 FY2023 | Dec 31, 2023 | -$87.00K | -341.7% |
| Q3 FY2023 | Sep 30, 2023 | $344.00K | +132.4% |
| Q2 FY2023 | Jun 30, 2023 | $175.00K | +73.3% |
| Q1 FY2023 | Mar 31, 2023 | -$57.00K | – |
| Q4 FY2022 | Dec 31, 2022 | $36.00K | -65.0% |
| Q3 FY2022 | Sep 30, 2022 | $148.00K | – |
| Q2 FY2022 | Jun 30, 2022 | $101.00K | +2425.0% |
| Q1 FY2022 | Mar 31, 2022 | -$22.00K | – |
| Q4 FY2021 | Dec 31, 2021 | $103.00K | – |
| Q3 FY2021 | Sep 30, 2021 | -$57.00K | – |
| Q2 FY2021 | Jun 30, 2021 | $4.00K | – |
| Q1 FY2021 | Mar 31, 2021 | -$42.00K | -162.7% |
| Q4 FY2020 | Dec 31, 2020 | -$138.00K | – |
| Q3 FY2020 | Sep 30, 2020 | -$27.00K | -136.5% |
| Q2 FY2020 | Jun 30, 2020 | -$85.00K | – |
| Q1 FY2020 | Mar 31, 2020 | $67.00K | – |
| Q4 FY2019 | Dec 31, 2019 | -$37.00K | -141.1% |
| Q3 FY2019 | Sep 30, 2019 | $74.00K | – |
| Q2 FY2019 | Jun 30, 2019 | -$66.00K | -123.2% |
| Q1 FY2019 | Mar 31, 2019 | -$108.00K | – |
| Q4 FY2018 | Dec 31, 2018 | $90.00K | – |
| Q3 FY2018 | Sep 30, 2018 | -$10.00K | – |
| Q2 FY2018 | Jun 30, 2018 | $285.00K | – |